<HTTP://PATHWAYCOMMONS.ORG/PSI2BP#_2943371078697328260> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.biopax.org/release/biopax-level3.owl#Evidence> .
<HTTP://PATHWAYCOMMONS.ORG/PSI2BP#_2943371078697328260> <http://www.biopax.org/release/biopax-level3.owl#comment> "Cancer - Interactions investigated in the context of cancer dataset MI:0875"^^<http://www.w3.org/2001/XMLSchema#string> .
<HTTP://PATHWAYCOMMONS.ORG/PSI2BP#_2943371078697328260> <http://www.biopax.org/release/biopax-level3.owl#comment> "imex curation MI:0959"^^<http://www.w3.org/2001/XMLSchema#string> .
<HTTP://PATHWAYCOMMONS.ORG/PSI2BP#_2943371078697328260> <http://www.biopax.org/release/biopax-level3.owl#comment> "Only protein-protein interactions full coverage MI:0957"^^<http://www.w3.org/2001/XMLSchema#string> .
<HTTP://PATHWAYCOMMONS.ORG/PSI2BP#_2943371078697328260> <http://www.biopax.org/release/biopax-level3.owl#comment> "imex curation curation depth MI:0955"^^<http://www.w3.org/2001/XMLSchema#string> .
<HTTP://PATHWAYCOMMONS.ORG/PSI2BP#_2943371078697328260> <http://www.biopax.org/release/biopax-level3.owl#comment> "Cancer Cell (1535-6108) journal MI:0885"^^<http://www.w3.org/2001/XMLSchema#string> .
<HTTP://PATHWAYCOMMONS.ORG/PSI2BP#_2943371078697328260> <http://www.biopax.org/release/biopax-level3.owl#comment> "2011 publication year MI:0886"^^<http://www.w3.org/2001/XMLSchema#string> .
<HTTP://PATHWAYCOMMONS.ORG/PSI2BP#_2943371078697328260> <http://www.biopax.org/release/biopax-level3.owl#comment> "Kim H.S., Vassilopoulos A., Wang R.H., Lahusen T., Xiao Z., Xu X., Li C., Veenstra T.D., Li B., Yu H., Ji J., Wang X.W., Park S.H., Cha Y.I., Gius D., Deng C.X. author-list MI:0636"^^<http://www.w3.org/2001/XMLSchema#string> .
<HTTP://PATHWAYCOMMONS.ORG/PSI2BP#_2943371078697328260> <http://www.biopax.org/release/biopax-level3.owl#comment> "chuxiad@bdg10.niddk.nih.gov contact-email MI:0634"^^<http://www.w3.org/2001/XMLSchema#string> .
<HTTP://PATHWAYCOMMONS.ORG/PSI2BP#_2943371078697328260> <http://www.biopax.org/release/biopax-level3.owl#comment> "SIRT2 Maintains Genome Integrity and Suppresses Tumorigenesis through Regulating APC/C Activity."^^<http://www.w3.org/2001/XMLSchema#string> .
<HTTP://PATHWAYCOMMONS.ORG/PSI2BP#_2943371078697328260> <http://www.biopax.org/release/biopax-level3.owl#comment> "The authors have confirmed that the IPs shown in Figs 6A/B were carried out using HeLa cells. comment MI:0612"^^<http://www.w3.org/2001/XMLSchema#string> .
<HTTP://PATHWAYCOMMONS.ORG/PSI2BP#_2943371078697328260> <http://www.biopax.org/release/biopax-level3.owl#comment> "The protein referred to as \"CDH1\" was identified as (Gene name)  FZR1 - Fizzy-related protein homolog/Cdh1/Hct1 homolog,  rather than (Gene name) CDH1 -Cadherin-1/CD324,  on the basis of  sequence/mutation location  info given in this paper.\nCdh1-HA/Myc/Flag and Cdc20-HA/Myc/Flag constructs were found to be Human in origin, according to the Addgene web site. data-processing MI:0633"^^<http://www.w3.org/2001/XMLSchema#string> .
<HTTP://PATHWAYCOMMONS.ORG/PSI2BP#_2943371078697328260> <http://www.biopax.org/release/biopax-level3.owl#xref> <HTTP://PATHWAYCOMMONS.ORG/PSI2BP#RXR-IM-16607> .
<HTTP://PATHWAYCOMMONS.ORG/PSI2BP#_2943371078697328260> <http://www.biopax.org/release/biopax-level3.owl#xref> <HTTP://PATHWAYCOMMONS.ORG/PSI2BP#PXR-22014574> .
<HTTP://PATHWAYCOMMONS.ORG/PSI2BP#_2943371078697328260> <http://www.biopax.org/release/biopax-level3.owl#xref> <HTTP://PATHWAYCOMMONS.ORG/PSI2BP#UXR-EBI-5238443> .
<HTTP://PATHWAYCOMMONS.ORG/PSI2BP#_2943371078697328260> <http://www.biopax.org/release/biopax-level3.owl#experimentalForm> <HTTP://PATHWAYCOMMONS.ORG/PSI2BP#_3154615862685810245> .
<HTTP://PATHWAYCOMMONS.ORG/PSI2BP#_2943371078697328260> <http://www.biopax.org/release/biopax-level3.owl#experimentalForm> <HTTP://PATHWAYCOMMONS.ORG/PSI2BP#_4414434750458298893> .
<HTTP://PATHWAYCOMMONS.ORG/PSI2BP#_2943371078697328260> <http://www.biopax.org/release/biopax-level3.owl#experimentalForm> <HTTP://PATHWAYCOMMONS.ORG/PSI2BP#_3202840786791381816> .